Replies to post #373668 on Amarin Corp Plc (AMRN)

[ggwpq]

"lawsuit over R-IT patent infringment." is no big deal for generics whose business models are revolved around lawsuits and filing sNDA. All you need is one generic who files an sNDA, the other leeches would follow.

[Bolio98]

You're confusing me N7.

When regulatory exclusivity expires for the R-IT indication

SNDA filing would trigger another lawsuit over R-IT patent infringment

Even if regulatory exclusivity expires an SNDA is required, I believe, and that's what I was referring to. So your fist quote trumps the second quote. Unless an SNDA is filed prior to exclusivity expiring.